|Articles|October 1, 2019
- BioPharm International-10-01-2019
- Volume 32
- Issue 10
BioPharm International, October 2019 Issue (PDF)
Click the title above to open the BioPharm International October 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Driving Improved Access to Biosimilarsabout 6 years ago
Technology Redefines Continuous Processing Efficiencyabout 6 years ago
Image Repair Must Start with the Root Causeabout 6 years ago
Best Practices for Selecting a Top-Quality Cell Lineabout 6 years ago
Data Integrity Violations Draw Strong FDA Rebukesabout 6 years ago
ALCOA+ and Data Integrityabout 6 years ago
Stability Indicating Methods for Aluminum Adsorbed Vaccine Productsabout 6 years ago
Using Software in Process Validationabout 6 years ago
Streamlining Operations in Fill/Finishabout 6 years ago
Outsourcing Early Development OperationsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
